TriMas (TRS) is back in front of beauty and fragrance buyers, with its packaging arm showcasing dispensing, closure and customized solutions at LUXE PACK Monaco and Beautyworld Dubai this fall.
TriMas shares last closed at US$38.70, with a 1-day share price return of 2.22% and a 90-day share price return down 11.24%. The 3-year total shareholder return of 62.66% contrasts with a modest 1-year total shareholder return decline of 1.81%, highlighting a difference between longer-term performance and more recent trading as the market absorbs recent packaging announcements and other updates into expectations.
Scan beyond TriMas and see how other packaging and materials players with strong fundamentals are lining up in the list of solid balance sheet and fundamentals (23 results).
TriMas has solid multi year returns on the board, yet the recent pullback hints more at shifting mood than a sharp change in the packaging business. So how does that mix show up in the current valuation?
On the most followed view of TriMas, a fair value of $45 sits above the last close at $38.70. This frames the current packaging news against a market that is still pricing in a discount.
New leadership with significant packaging industry expertise is implementing operational standardization and integration across global manufacturing sites and recent acquisitions. This push is expected to drive margin expansion and improved operating leverage, positively impacting net margins and earnings potential.
See why 1 investors see TriMas as 14% undervalued.
Result: Fair Value of $45 (UNDERVALUED)
Still, the TriMas story can break if integration drags or regulators tighten packaging rules faster than its product mix and cost structure can adapt.
Find out about the key risks to this TriMas narrative.
The 14% upside narrative leans on earnings forecasts and a fair value of $45. On a simpler yardstick, TriMas trades on a P/E of 16.6x, above the global packaging average of 15.3x and slightly above its own fair ratio of 16.3x. That points to only a thin margin of safety. Which signal do you trust more?
See what the numbers say about this price in our valuation breakdown, then weigh it against your own expectations for the business. See what the numbers say about this price — find out in our valuation breakdown.
Mixed signals around TriMas valuation and sentiment do not have to leave you on the fence. Move quickly to review the data that matters most to you and weigh both sides of the story with the 3 key rewards and 1 important warning sign
Do not stop with TriMas. Broaden your watchlist with fresh ideas that line up with the kind of quality, value and resilience you want working for you.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com